Embecta Corp EMBC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Embecta Corp. (EMBC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
-
Robbins LLP Reminds EMBC Stockholders of the Securities Fraud Class Action; Contact the Firm for Information About Your Rights
-
EMBC Shareholder Alert: August 17, 2026 Lead Plaintiff Deadline in Embecta Corp. Securities Class Action - Contact SueWallSt
-
EMBC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Embecta Corp. Securities Lawsuit - Contact Levi & Korsinsky
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines - EMBC
-
EMBC INVESTOR DEADLINE: Embecta Corp. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit— HBSS
-
EMBC Fraud Notice: Embecta Investors are Reminded to Contact BFA Law about the Filed Securities Fraud Class Action Lawsuit to Recover Investment Losses
-
Lost Money on Embecta Corp. (EMBC)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
Trading Information
- Previous Close Price
- $3.35
- Day Range
- $3.25–3.41
- 52-Week Range
- $2.77–15.55
- Bid/Ask
- $3.20 / $3.31
- Shares Outstanding
- 59.33M
- Market Cap
- $192.81M
- Volume/Avg
- 1M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 1.57
- Price/Sales
- 0.19
- Dividend Yield (Trailing)
- 14.15%
- Dividend Yield (Forward)
- 14.15%
- Total Yield
- 14.15%
Company Profile
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,850
- Website
- https://www.embecta.com
Valuation
|
Metric
|
EMBC
|
|---|---|
Price/Earnings (Normalized) | 1.57 |
Price/Book Value | — |
Price/Sales | 0.19 |
Price/Cash Flow | 0.91 |
Price/Earnings
EMBC
Financial Strength
|
Metric
|
EMBC
|
|---|---|
Quick Ratio | 1.34 |
Current Ratio | 2.46 |
Interest Coverage | 2.71 |
Quick Ratio
EMBC
Profitability
|
Metric
|
EMBC
|
|---|---|
Return on Assets (Normalized) | 14.03% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 27.79% |
Return on Assets
EMBC
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|Lw^&ws& | LOCK|#& | $122B | |||
| Becton Dickinson & Co
BDX
| LOCK|X$# | LOCK|^@?k | $44B | |||
| Alcon Inc
ALC
| LOCK|FS?<#m | LOCK|<djhW | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|rPXwNkB | LOCK|#M&& | $34B | |||
| ResMed Inc
RMD
| LOCK|?qFl%q# | LOCK|#!b^ | $29B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|twkfbl>& | LOCK|SK | $25B | |||
| Solventum Corp
SOLV
| LOCK|?TGV?VR | LOCK|>P | $14B | |||
| The Cooper Companies Inc
COO
| LOCK|<?$dTd | LOCK|V^>d? | $14B | |||
| Align Technology Inc
ALGN
| LOCK|<<xZ%C | LOCK|%pH& | $13B | |||
| Baxter International Inc
BAX
| LOCK|?ZR | LOCK|<QVt | $12B |
United States